Results
37
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
37 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AAUC | CA$3.11 | -5.8% | n/a | CA$779.8m | CA$8.33 | PB1.9x | E73.6% | n/a | Materials | ||
AII | CA$0.80 | 0% | 61.6% | CA$201.7m | CA$2.31 | PS8.1x | E117.6% | n/a | Materials | ||
VOXR | CA$3.72 | 2.5% | 27.4% | CA$184.4m | CA$5.74 | PE2585.9x | E70.7% | 1.7% | Materials | ||
ACOG | CA$0.58 | -3.3% | 52.6% | CA$89.0m | CA$2.00 | PE-4x | E69.5% | n/a | Pharmaceuticals & Biotech | ||
PRL | CA$29.63 | 9.9% | 234.0% | CA$992.0m | CA$32.72 | PE19.4x | E37.2% | 1.7% | Diversified Financials | ||
ALV | CA$5.05 | -1.0% | -48.5% | CA$184.6m | CA$7.75 | PE10.3x | E72.4% | 9.6% | Energy | ||
ROK | CA$0.20 | -2.4% | -44.6% | CA$45.9m | n/a | PB0.5x | E161.8% | n/a | Energy | ||
MDNA | CA$2.18 | 3.3% | 327.5% | CA$159.2m | CA$4.73 | PB7.3x | E57.2% | n/a | Pharmaceuticals & Biotech | ||
GSY | CA$187.78 | 2.2% | 48.7% | CA$3.1b | CA$236.25 | PE11.9x | E17.1% | 2.5% | Diversified Financials | ||
AYA | CA$14.94 | -6.9% | 80.7% | CA$1.9b | CA$20.77 | PE156.2x | E60.9% | n/a | Materials | ||
PAY | CA$8.68 | 12.0% | 23.6% | CA$396.3m | CA$12.00 | PE21.1x | E24.7% | n/a | Diversified Financials | ||
IVN | CA$17.87 | -1.1% | 48.7% | CA$24.2b | CA$23.73 | PE118.4x | E72.4% | n/a | Materials | ||
AGX | CA$0.20 | -13.0% | -13.0% | CA$41.1m | n/a | PS1.9x | n/a | n/a | Materials | ||
NICU | CA$0.81 | 9.5% | 35.0% | CA$139.7m | CA$1.43 | PB7.2x | E103.7% | n/a | Materials | ||
ARTG | CA$12.12 | -7.3% | 98.4% | CA$2.7b | CA$15.73 | PB4.6x | E47.4% | n/a | Materials | ||
TM | CA$0.71 | -5.3% | -30.7% | CA$31.8m | CA$3.23 | PE34.2x | E51.2% | n/a | Materials | ||
GAME | CA$1.80 | -0.6% | n/a | CA$54.6m | n/a | PB1.2x | E86.6% | n/a | Media | ||
NOA | CA$27.05 | 6.3% | -19.1% | CA$686.3m | CA$36.25 | PE13.3x | E35.6% | 1.5% | Energy | ||
ELVA | CA$2.67 | -5.3% | -38.9% | CA$91.1m | CA$16.61 | PE114.2x | E59.2% | n/a | Capital Goods | ||
CURA | CA$3.91 | -7.8% | -21.8% | CA$2.8b | CA$11.69 | PS1.6x | E78.2% | n/a | Pharmaceuticals & Biotech | ||
SIS | CA$19.89 | 1.5% | 23.5% | CA$1.4b | CA$24.33 | PE31.4x | E21.5% | 2.6% | Capital Goods | ||
ACX | CA$6.29 | 1.5% | 2.1% | CA$216.5m | CA$11.98 | PE9.1x | E61.2% | 0% | Energy | ||
GCL | CA$1.34 | 1.5% | 27.6% | CA$136.7m | CA$1.93 | PE36x | E46.2% | 0% | Consumer Retailing | ||
ARG | CA$1.65 | -2.4% | 15.4% | CA$272.2m | n/a | PE16.7x | E52.8% | 7.1% | Materials |